Search alternatives:
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
-
3621
-
3622
-
3623
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3624
-
3625
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3626
-
3627
-
3628
-
3629
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3630
-
3631
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3632
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3633
-
3634
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3635
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3636
-
3637
Potential metabolites in the colonic tissue related with diarrhea induced by FSE.
Published 2025Subjects: -
3638
-
3639
-
3640
Heatmap and pathway analysis of the potential metabolites in colon tissue related with diarrhea.
Published 2025Subjects: